Results 181 to 190 of about 1,281,552 (342)
Objectives This study aims to develop hip morphology‐based radiographic hip osteoarthritis (RHOA) risk prediction models and investigates the added predictive value of hip morphology measurements and the generalizability to different populations. Methods We combined data from nine prospective cohort studies participating in the World COACH consortium ...
Myrthe A. van den Berg +26 more
wiley +1 more source
Effectiveness and Cost‐Benefit of an Influenza Vaccination Program for Health Care Workers [PDF]
Annalee Yassi +4 more
openalex +1 more source
Objectives This study aims to describe the frequency and timing of physician referrals to physical therapists (PT) and other treatments prescribed over 12 months in patients with recent onset of knee osteoarthritis (KOA). The study also aims to identify determinants of early PT referrals.
Samannaaz S. Khoja +4 more
wiley +1 more source
Prevention: the cost-effectiveness of the California Diabetes and Pregnancy Program. [PDF]
R M Scheffler +2 more
openalex +1 more source
Cost-effectiveness of lenalidomide [PDF]
Esmeralda Ríos Sánchez +4 more
openaire +3 more sources
Objective The aim of this study was to investigate the cost‐effectiveness of low‐dose colchicine prophylaxis for preventing gout flares when starting allopurinol using the “start‐low go‐slow” approach. Methods Participants with gout, fulfilling the American College of Rheumatology recommendations for starting urate‐lowering therapy and with serum urate
Yana Pryymachenko +4 more
wiley +1 more source
Purpose We assessed whether circulating adipokines are associated with incident fractures in patients with rheumatoid arthritis (RA). Methods Three adipokines (adiponectin, leptin, fibroblast growth factor [FGF]‐21) were measured using banked enrollment serum from participants in a longitudinal RA cohort.
Joshua F. Baker +9 more
wiley +1 more source
Cost effectiveness of magnetic resonance imaging. [PDF]
Ala Szczepura +2 more
openalex +3 more sources
Cost-effectiveness of emicizumab for the treatment of hemophilia A: a systematic review. [PDF]
Chen M +5 more
europepmc +1 more source

